0.7258
前日終値:
$0.7352
開ける:
$0.76
24時間の取引高:
209.02K
Relative Volume:
0.63
時価総額:
$40.99M
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-4.32%
1か月 パフォーマンス:
-62.59%
6か月 パフォーマンス:
-70.73%
1年 パフォーマンス:
-82.55%
Tuhura Biosciences Inc Stock (HURA) Company Profile
名前
Tuhura Biosciences Inc
セクター
電話
813-875-6600
住所
10500 UNIVERSITY CENTER DR., TAMPA
HURA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
HURA
Tuhura Biosciences Inc
|
0.7258 | 41.52M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Tuhura Biosciences Inc Stock (HURA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-03 | 開始されました | H.C. Wainwright | Buy |
| 2024-12-19 | 開始されました | Rodman & Renshaw | Buy |
| 2024-11-05 | 開始されました | Maxim Group | Buy |
Tuhura Biosciences Inc (HURA) 最新ニュース
TuHURA Biosciences Inc Stock Analysis and ForecastRetail Trading Trends & Enter Your Email to Get Stock Alerts - earlytimes.in
Tuhura Biosciences amends loan agreement, secures full $3M - MSN
Is TuHURA Biosciences Inc PL3 a good long term investmentStop Loss Placement Tips & Big Profit Small Investment - earlytimes.in
What the Latest News Means for ABS Marine Services Limited Stock InvestorsTake Profit Strategies & Free Tremendous Portfolio Expansion - earlytimes.in
TUHURA Biosciences announces $15.6M registered direct offering - MSN
What analysts say about TuHURA Biosciences Inc PL3 stockEvening Star Patterns & Don’t Miss These Undervalued Stocks - earlytimes.in
Analysts Offer Insights on Healthcare Companies: Actinogen Medical (OtherATGGF) and TuHURA Biosciences (HURA) - The Globe and Mail
Does TuHURA Biosciences Inc. stock trade at a discount to peers2025 Buyback Activity & Free Real-Time Market Sentiment Alerts - Улправда
Is TuHURA Biosciences Inc. stock supported by innovation pipelineTrend Reversal & Growth Focused Entry Point Reports - Улправда
Will TuHURA Biosciences Inc. (PL3) stock attract long term capital inflows2025 Technical Patterns & Expert Verified Movement Alerts - Улправда
Volume Summary: Does TuHURA Biosciences Inc. stock trade at a discount to peers2025 Trade Ideas & Free Safe Capital Growth Stock Tips - Улправда
Will TuHURA Biosciences Inc. stock gain from lower inflationGold Moves & High Accuracy Swing Trade Signals - Улправда
Can TuHURA Biosciences Inc. stock reach $100 price targetPortfolio Update Summary & High Accuracy Trade Signal Alerts - Улправда
Aug Retail: How TuHURA Biosciences Inc. stock compares to industry benchmarksWeekly Profit Recap & Consistent Return Strategy Ideas - Улправда
Can TuHURA Biosciences Inc. (PL3) stock expand revenue streams2025 Breakouts & Breakdowns & Stepwise Trade Signal Implementation - Улправда
How TuHURA Biosciences Inc. stock compares to industry benchmarksTrade Ideas & Consistent Growth Equity Picks - Улправда
Will TuHURA Biosciences Inc. stock outperform Nasdaq indexPortfolio Performance Report & Capital Efficiency Focused Ideas - Улправда
Will TuHURA Biosciences Inc. stock deliver shareholder valueTrade Volume Report & Free Expert Approved Momentum Trade Ideas - Улправда
Is TuHURA Biosciences Inc. (PL3) stock a top pick for value investors2025 Trading Recap & Stepwise Trade Signal Implementation - Улправда
Can TuHURA Biosciences Inc. stock sustain free cash flow growth2025 Stock Rankings & Weekly High Potential Stock Alerts - DonanımHaber
Can TuHURA Biosciences Inc. stock weather global recessionWeekly Loss Report & Growth Focused Stock Reports - Улправда
TuHURA Biosciences Earnings Notes - Trefis
Why TuHURA Biosciences Inc. stock could see breakout soon2025 Market Outlook & Free AI Powered Buy and Sell Recommendations - Улправда
Bull Run: Will TuHURA Biosciences Inc. stock benefit from green energy trendsPortfolio Performance Report & Risk Controlled Stock Pick Alerts - Улправда
Rate Hike: Can TuHURA Biosciences Inc. (PL3) stock expand revenue streamsCEO Change & Weekly Top Gainers Alerts - Улправда
[Form 4] TuHURA Biosciences, Inc./NV Insider Trading Activity - Stock Titan
TuHURA Biosciences, Inc. (HURA) CEO discloses 3.4M option grant terms in filing - Stock Titan
TuHURA Biosciences, Inc. (NASDAQ:HURA) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
TuHURA Biosciences, Inc. (NASDAQ:HURA) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
TuHURA Biosciences Announces Its Release of Kintara's Contingent Value Right (CVR) as Kintara's REM-001 Meets Primary Safety Endpoint Achieving Contractual Milestone - 富途牛牛
TuHURA Biosciences announces release of Kintara’s CVR - TipRanks
TuHURA to release shares to Kintara CVR holders as trial meets endpoint - Investing.com Nigeria
TuHURA to release shares to Kintara CVR holders as trial meets endpoint By Investing.com - Investing.com South Africa
Tuhura Biosciences releases Kintara CVR after safety milestone - marketscreener.com
TuHURA Biosciences (NASDAQ:HURA) Rating Lowered to Sell at Wall Street Zen - MarketBeat
TuHURA Biosciences provides corporate update after $15.6M financing By Investing.com - Investing.com South Africa
TuHURA Biosciences Provides Corporate Update Following Recent Financing - Sahm
TuHURA Biosciences provides corporate update after $15.6M financing - Investing.com
TuHURA Biosciences Announces Securities Purchase Agreement - TipRanks
Big Drops For Top Wealth, TuHURA Biosciences, And AutoZone - Finimize
TuHURA Biosciences presents research on potential role of DOR at ASH - MSN
Top US Stock Market Losers Today (December 9, 2025): HURA, Phreesia, Virgin Galactic, SLM, Gogo and More - ts2.tech
TuHURA Biosciences announces $15.6M registered direct offering - TipRanks
TuHURA Biosciences plunges after $15.6 million direct stock deal - TradingView — Track All Markets
TuHURA Biosciences announces $15.6 million registered direct offering - Investing.com
TuHURA Biosciences announces $15.6 million registered direct offering By Investing.com - Investing.com Australia
Tuhura Biosciences Inc (HURA) 財務データ
Tuhura Biosciences Inc (HURA) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):